| Brainstorm | New from Reddit (test): COVID19_Pandemic: COVID-19 Infection and Coronary Plaque Progression: An Early Warning of a Potential Public Health Crisis → https://old.reddit.com/r/COVID19_Pandemic/comments/1ihvh4u/covid19_infection_and_coronary_plaque_progression/ | 00:34 |
|---|---|---|
| Brainstorm | New from Reddit (test): COVID19_Pandemic: Early Adult Death Rising in the US: Pre- and Postpandemic Trends → https://old.reddit.com/r/COVID19_Pandemic/comments/1ii34w8/early_adult_death_rising_in_the_us_pre_and/ | 08:57 |
| Brainstorm | New from NPR Science: The colorful community of microbes hiding in Yellowstone's hot springs: For a long time, microbes like the ones in Yellowstone's hot springs were studied in isolation. Molecular ecologist Devaki Bhaya says we should be studying them in community. Here's why. → https://www.npr.org/2025/02/05/1229167010/yellowstone-bacteria-hot-springs-microbes-relationship | 09:07 |
| Brainstorm | New from BMJ Open: The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial: Introduction Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic lung disease [... want %more?] → http://bmjopen.bmj.com/cgi/content/short/15/2/e088604 | 10:36 |
| Brainstorm | New from EMA: What's new: (news): Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 20/12/2021, Revision: 15, Status: Authorised → https://www.ema.europa.eu/en/medicines/human/EPAR/nuvaxovid | 11:46 |
| Brainstorm | New from PubMed: A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings: CONCLUSIONS: Marked reduction in inflammatory signaling with preserved SARS-CoV-2 serological response was observed in hospitalized patients [... want %more?] → https://pubmed.ncbi.nlm.nih.gov/39906744/ | 12:26 |
| Brainstorm | New from Marc Veldhoen on Mastodon: (news): Cognition and Memory after Covid-19 in a Large Community Sample → https://mastodon.online/@marc_veld/113951340030224204 | 13:47 |
| Brainstorm | New from EMA: What's new: (news): Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn → https://www.ema.europa.eu/en/medicines/human/EPAR/penbraya | 14:46 |
| Brainstorm | New from Marc Veldhoen on Mastodon: (news): Eligible XBB.1.5 vaccine recipients were matched 1:1 to unvaccinated persons in 7 sequential biweekly trials with enrollment from 2 October 2023 through 3 January 2024. → https://mastodon.online/@marc_veld/113951850140506903 | 15:56 |
| Brainstorm | New from StatNews: STAT+: The MAHA era is here. RFK Jr.’s troubles are only beginning: The MAHA era has begun. But to execute his promises on health, RFK Jr. faces tough challenges on vaccines, chronic disease, and big business. → https://www.statnews.com/2025/02/05/rfk-jr-maha-movement-health-secretary-challenge-make-america-healthy-again/ | 17:05 |
| Brainstorm | New from CIDRAP: Nearly 30% of cats, dogs owned by COVID patients had SARS-CoV-2 antibodies by 2021: In total, 5% of dogs and 13% of cats tested positive for COVID-19 on polymerase chain reaction, and 25% and 36%, respectively, had SARS-CoV-2 neutralizing antibodies. → https://www.cidrap.umn.edu/covid-19/nearly-30-cats-dogs-owned-covid-patients-had-sars-cov-2-antibodies-2021 | 17:15 |
| Brainstorm | New from Contagion Live: Novavax’s Updated COVID-19 Vaccine's Continue to Enhance Immune Response: The latest Phase 2/3 trial results show NVX-CoV2601 outperforms its predecessor, offering protection against emerging COVID-19 strains. → https://www.contagionlive.com/view/novavax-s-updated-covid-19-vaccine-demonstrates-enhanced-immune-response-in-recent-study | 19:51 |
| Brainstorm | New from CIDRAP: Report: Severe COVID can catalyze arterial plaque growth, sparking deadly heart problems: Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year. → https://www.cidrap.umn.edu/covid-19/report-severe-covid-can-catalyze-arterial-plaque-growth-sparking-deadly-heart-problems | 20:11 |
| Brainstorm | New from MedPageToday: Common Bacterial Infection Might Be Key to Lung Transplant Rejection: (MedPage Today) -- After lung transplantation, infection with Pseudomonas aeruginosa independently predicted antibody-mediated rejection (AMR), researchers found.Individuals found to carry the bacteria after [... want %more?] → https://www.medpagetoday.com/pulmonology/generalpulmonary/114090 | 20:31 |
| Brainstorm | New from Contagion Live: COVID-19 Accelerates Progression of Atherosclerotic Plaque, Increases Risk for Cardiovascular Events: SARS-CoV-2 infection was associated with rapid growth of plaque in the coronary arteries and an increased risk of [... want %more?] → https://www.contagionlive.com/view/covid-19-accelerates-progression-of-atherosclerotic-plaque-increases-risk-for-cardiovascular-events | 22:09 |
| LjL | ublx, ↑ sounds like your covid specialty ;( | 22:17 |
| Brainstorm | New from ##covid-19 Zotero group: COVID-19 Italia - Desktop: Item Type Web Page URL https://opendatamds.maps.arcgis.com/apps/dashboards/0f1c9a02467b45a7b4ca12d8ba296596 Accessed 2025-02-05 21:23:32 → https://www.zotero.org/groups/covid_links/items/SMLK4B4M | 22:28 |
| ublx | *arteries twinge and recoil in horror* | 22:32 |
| Brainstorm | New from Reddit (test): Let the minimizers at the NYT have it...: How Did Covid Change Your Life? - The New York Times → https://www.nytimes.com/2025/02/05/us/covid-pandemic-changes.html | 23:26 |
Generated by irclog2html.py 2.17.0 by Marius Gedminas - find it at https://mg.pov.lt/irclog2html/!